The Inhibitory Effect of Botulinum Toxin Type A on Rat Pyloric Smooth Muscle Contractile Response to Substance P In Vitro

The Inhibitory Effect of Botulinum Toxin Type A on Rat Pyloric Smooth Muscle Contractile Response to Substance P In Vitro

A decrease in pyloric myoelectrical activity and pyloric substance P (SP) content following intrasphincteric injection of botulinum toxin type A (BTX-A) in free move rats have been demonstrated in our previous studies. The aim of the present study was to investigate the inhibitory effect of BTX-A on...

Full description

Bibliographic Details
Main Authors:	Yu-Feng Shao, Jun-Fan Xie, Yin-Xiang Ren, Can Wang, Xiang-Pan Kong, Xiao-Jian Zong, Lin-Lan Fan, Yi-Ping Hou
Format:	Article
Language:	English
Published:	MDPI AG 2015-10-01
Series:	Toxins
Subjects:	botulinum toxin type A substance P electric field stimulation neurokinin 1 receptor antagonist of neurokinin 1 receptor pyloric smooth muscle contractility rat
Online Access:	http://www.mdpi.com/2072-6651/7/10/4143

Similar Items

Tachykinin: recent developments and novel roles in health and disease
by: Onaga Takenori
Published: (2014-06-01)

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
by: Paweł K. Halik, et al.
Published: (2020-08-01)

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant
by: Muath Mohammed Abu Hilal
Published: (2011-01-01)

Elevated Neurokinin-1 Receptor Expression in Uterine Products of Conception Is Associated With First Trimester Miscarriages
by: Ahmad Alwazzan, et al.
Published: (2020-12-01)

Tachykinins: Neuropeptides That Are Ancient, Diverse, Widespread and Functionally Pleiotropic
by: Dick R. Nässel, et al.
Published: (2019-11-01)

THE NEURONAL CIRCUITRY OF ESTROGENIC EFFECTS ON THERMOREGULATION
by: Dacks, Penny Ann Frances
Published: (2010)

High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis
by: Chen XY, et al.
Published: (2016-06-01)

Neurokinin-1 receptor activation in globus pallidus
by: Lei Chen, et al.
Published: (2009-10-01)

Expression of substance P and neurokinin-1 receptor in nasopharyngeal carcinoma and their clinical significance
by: ZHANG Yu, et al.
Published: (2020-07-01)

Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor
by: Duy-Khanh Dang, et al.
Published: (2018-02-01)

Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)
by: Athanasios Tsianakas, et al.
Published: (2019-02-01)

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
by: Navari RM, et al.
Published: (2018-10-01)

Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations
by: Rapoport BL, et al.
Published: (2017-09-01)

Management of chemotherapy induced emesis
by: Roila Fausto
Published: (2004-01-01)

Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
by: Riffat Mehboob
Published: (2021-11-01)

Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes
by: Magdalena Chottova Dvorakova, et al.
Published: (2018-07-01)

Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo
by: Wu H, et al.
Published: (2020-06-01)

Localisation cellulaire et subcellulaire des récepteurs de type neurokinine-1 et neurokinine-3 dans le globus pallidus du primate
by: Parent, Rémy
Published: (2008)

Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P
by: Amanda R. Burmeister, et al.
Published: (2017-12-01)

Development of Neuropeptide Receptor Ligands for the Control of Reproductive Systems
by: Misu, Ryosuke
Published: (2015)

Neurokinin receptors and their implications in various autoimmune diseases
by: Amrita Mishra, et al.
Published: (2021-01-01)

Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system
by: Fatemeh Ghahremani, et al.
Published: (2021-04-01)

The role of neurokinin-1 (substance P) antagonists in the prevention of postoperative nausea and vomiting
by: Dionne Okafor, et al.
Published: (2017-01-01)

Spotlight on the perioperative use of maropitant citrate
by: Hay Kraus BL
Published: (2017-08-01)

Cholera Toxin Induces Sustained Hyperexcitability in Myenteric, but Not Submucosal, AH Neurons in Guinea Pig Jejunum
by: Joel C. Bornstein, et al.
Published: (2017-04-01)

Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment
by: Shoko Yoshida, et al.
Published: (2021-06-01)

Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation
by: Hannah D. Fulenwider, et al.
Published: (2018-02-01)

Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis
by: Louise Lönndahl, et al.
Published: (2017-12-01)

The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
by: Agnieszka Majkowska-Pilip, et al.
Published: (2019-09-01)

The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity
by: Fu-Xing-Zi Li, et al.
Published: (2020-02-01)

Neurokinin receptors in the gastrointestinal muscle wall: cell distribution and possible roles
by: Vannucchi Maria Giuliana, et al.
Published: (2013-06-01)

Cystathionine-Gamma-Lyase-Derived Hydrogen Sulfide-Regulated Substance P Modulates Liver Sieve Fenestrations in Caecal Ligation and Puncture-Induced Sepsis
by: Ravinder R Gaddam, et al.
Published: (2019-06-01)

Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting
by: Rapoport BL
Published: (2017-02-01)

Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
by: Iris Beirith, et al.
Published: (2021-05-01)

The Cattle Fever Tick, Rhipicephalus microplus, as a Model for Forward Pharmacology to Elucidate Kinin GPCR Function in the Acari
by: Caixing Xiong, et al.
Published: (2019-08-01)

The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
by: Se-Jin Lee, et al.
Published: (2012-09-01)

IGFs Potentiate TAC3-induced SLα Expression via Upregulation of TACR3 Expression in Grass Carp Pituitary Cells
by: Guangfu Hu, et al.
Published: (2019-08-01)

<it>In vivo </it>antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
by: Guillemyn Karel, et al.
Published: (2012-01-01)

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
by: Vasilios M. Polymeropoulos, et al.
Published: (2020-09-01)

Treatment-resistant prurigo nodularis: challenges and solutions
by: Kowalski EH, et al.
Published: (2019-02-01)